Wellfully Ltd (WFL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Wellfully Ltd (WFL) has a cash flow conversion efficiency ratio of -0.017x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$28.49K ≈ $20.16K USD) by net assets (AU$-1.69 Million ≈ $-1.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Wellfully Ltd to measure how much of total assets are equity-financed.
Wellfully Ltd - Cash Flow Conversion Efficiency Trend (2015–2022)
This chart illustrates how Wellfully Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Wellfully Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Wellfully Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wellfully Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
1Spatial PLC
LSE:SPA
|
0.062x |
|
Value & Income Trust
LSE:VIP
|
0.013x |
|
Biomotion Sciences Ordinary Shares
NASDAQ:SLXN
|
-12.529x |
|
Marksmen Energy Inc
V:MAH
|
-0.009x |
|
Semilux International Ltd. Ordinary Shares
NASDAQ:SELX
|
-0.064x |
|
POLAREAN IMAG.LS-00037
F:8ZF
|
N/A |
|
Golden Prospect Precious Metals Ltd
LSE:GPM
|
-0.016x |
|
The Pebble Group PLC
LSE:PEBB
|
0.180x |
Annual Cash Flow Conversion Efficiency for Wellfully Ltd (2015–2022)
The table below shows the annual cash flow conversion efficiency of Wellfully Ltd from 2015 to 2022. For the full company profile with market capitalisation and key ratios, see Wellfully Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | AU$-1.71 Million ≈ $-1.21 Million |
AU$-2.44 Million ≈ $-1.73 Million |
1.429x | +110.73% |
| 2021-12-31 | AU$619.56K ≈ $438.38K |
AU$-8.25 Million ≈ $-5.84 Million |
-13.314x | -490.90% |
| 2020-12-31 | AU$2.31 Million ≈ $1.63 Million |
AU$-5.20 Million ≈ $-3.68 Million |
-2.253x | -202.62% |
| 2019-12-31 | AU$-1.22 Million ≈ $-862.54K |
AU$-2.68 Million ≈ $-1.89 Million |
2.196x | +397.85% |
| 2018-12-31 | AU$2.55 Million ≈ $1.80 Million |
AU$-1.88 Million ≈ $-1.33 Million |
-0.737x | -119.71% |
| 2017-12-31 | AU$4.26 Million ≈ $3.01 Million |
AU$-1.43 Million ≈ $-1.01 Million |
-0.336x | -13.45% |
| 2016-12-31 | AU$5.70 Million ≈ $4.03 Million |
AU$-1.69 Million ≈ $-1.19 Million |
-0.296x | +4.03% |
| 2015-12-31 | AU$7.28 Million ≈ $5.15 Million |
AU$-2.24 Million ≈ $-1.59 Million |
-0.308x | -- |
About Wellfully Ltd
Wellfully Limited, together with its subsidiaries, engages in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates through two segments, Dermaportation Drug Delivery Technology and Devices. It is involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT … Read more